Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03883984 · ClinicalTrials.gov registry record · Phase 1
Cysteamine for Asthma
A Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT03883984 is a Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 60 participants.
The verdict
NCT03883984, a Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a medicine called Cysteamine, given along with standard asthma care, will improve asthma symptoms and lung function.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Cysteamine Bitartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2021-02-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03883984
The ClinicalTrials.gov registry entry for NCT03883984 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT03883984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03883984 about?
NCT03883984 is a clinical study titled "Cysteamine for Asthma". The purpose of this study is to see if a medicine called Cysteamine, given along with standard asthma care, will improve asthma symptoms and lung function.
What is the current status of trial NCT03883984?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2019-06-18. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT03883984?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Cysteamine Bitartrate (DRUG).
Who is sponsoring clinical trial NCT03883984?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.